261 related articles for article (PubMed ID: 37627711)
21. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.
Shariati A; Dadashi M; Chegini Z; van Belkum A; Mirzaii M; Khoramrooz SS; Darban-Sarokhalil D
Antimicrob Resist Infect Control; 2020 Apr; 9(1):56. PubMed ID: 32321574
[TBL] [Abstract][Full Text] [Related]
22. Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis.
Ray L; Levasseur K; Nicolau DP; Scheetz MH
Ann Pharmacother; 2010 Mar; 44(3):582-6. PubMed ID: 20179255
[TBL] [Abstract][Full Text] [Related]
23. Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis.
Mader MM; Czorlich P; König C; Fuhrmann V; Kluge S; Westphal M; Grensemann J
Acta Neurochir (Wien); 2018 Nov; 160(11):2099-2105. PubMed ID: 30242495
[TBL] [Abstract][Full Text] [Related]
24. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
Mueller SW; Kiser TH; Anderson TA; Neumann RT
Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018
[TBL] [Abstract][Full Text] [Related]
25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
26. Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.
Eckmann C; Dryden M
Eur J Med Res; 2010 Nov; 15(12):554-63. PubMed ID: 21163730
[TBL] [Abstract][Full Text] [Related]
27. Newer treatment options for skin and soft tissue infections.
Raghavan M; Linden PK
Drugs; 2004; 64(15):1621-42. PubMed ID: 15257625
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic monitoring of cerebrospinal fluid vancomycin concentrations and analysis of their influencing factors in neurosurgical intensive care unit patients].
Yao M; Li J; Shi L; Li Y; Wang L; Guan X; Ouyang B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1252-1257. PubMed ID: 31771724
[TBL] [Abstract][Full Text] [Related]
29. A case of ventricular drainage infection with a rare pathogen in cerebrospinal fluid: vancomycin-resistant Enterococcus faecium.
Baysallar M; Izci Y; Kilic A; Avci IY; Senses Z; Doganci L
Microb Drug Resist; 2006; 12(1):59-62. PubMed ID: 16584310
[TBL] [Abstract][Full Text] [Related]
30. Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.
Li L; Li X; Xia Y; Chu Y; Zhong H; Li J; Liang P; Bu Y; Zhao R; Liao Y; Yang P; Lu X; Jiang S
Front Pharmacol; 2020; 11():786. PubMed ID: 32547394
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
32. The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis.
Burgess DS; Frei CR; Lewis Ii JS; Fiebelkorn KR; Jorgensen JH
Clin Microbiol Infect; 2007 Jan; 13(1):33-9. PubMed ID: 17184285
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis using linezolid without removal of intrathecal infusion pump. Case report.
Kallweit U; Harzheim M; Marklein G; Welt T; Pöhlau D
J Neurosurg; 2007 Sep; 107(3):651-3. PubMed ID: 17886567
[TBL] [Abstract][Full Text] [Related]
34. Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation.
Eagye KJ; Kuti JL; Dowzicky M; Nicolau DP
Clin Ther; 2007 May; 29(5):889-899. PubMed ID: 17697907
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
Quinn AL; Parada JP; Belmares J; O'Keefe JP
Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
[TBL] [Abstract][Full Text] [Related]
36. [Off label uses of tigecycline].
Ben Mabrouk A; Ben Brahim H; Kooli I; Marrakchi W; Aouam A; Loussaief C; Toumi A; Chakroun M
Ann Pharm Fr; 2021 May; 79(3):244-254. PubMed ID: 33289663
[TBL] [Abstract][Full Text] [Related]
37. Intraventricular CNS treatment with Colistin-Tigecycline combination: A case series.
Tsolaki V; Karvouniaris M; Manoulakas E; Kotlia P; Karadontas V; Fotakopoulos G; Zakynthinos E; Makris D
J Crit Care; 2018 Oct; 47():338-341. PubMed ID: 30097260
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of ventriculostomy-associated meningitis caused by multidrug resistant coagulase-negative Staphylococcus epidermidis using low-volume intrathecal daptomycin and loading strategy.
Denetclaw TH; Suehiro I; Wang PK; Tolliver GL
Ann Pharmacother; 2014 Oct; 48(10):1376-9. PubMed ID: 24994724
[TBL] [Abstract][Full Text] [Related]
39. Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria.
Jean SS; Liu IM; Hsieh PC; Kuo DH; Liu YL; Hsueh PR
Int J Antimicrob Agents; 2023 May; 61(5):106763. PubMed ID: 36804370
[TBL] [Abstract][Full Text] [Related]
40. Bacterial meningitis. Rational selection and use of antibacterial drugs.
Whitby M; Finch R
Drugs; 1986 Mar; 31(3):266-78. PubMed ID: 3519175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
